A simple finger-prick blood test for Alzheimers and dementia? The new Bio-Hermes-002 (2) study

Can a simple finger-prick blood test predict your risk of Alzheimers? In a new international trial, Canadians will join volunteers from the UK and US to test a ground-breaking blood test designed to detect biomarkers associated with the condition.
The Bio-Hermes-002 (2) study will help identify and assess the effectiveness of blood tests and digital tests such as CT scans which detect the presence of amyloid plaques or tau tangles in the brain.
What the blood test looks for
Alzheimer’s disease is marked by the presence of two “rogue” proteins, amyloid and tau, which can build up as plaques and tangles in the brain years before physical symptoms start to show.
Dr Giovanna Lalli, director of strategy and operations at LifeArc, said of the blood test:
“We are looking at the presence of three proteins that have been linked to Alzheimer’s disease, so-called blood-based biomarkers. By analysing the concentration and the levels of these proteins it may tell us whether a person is at risk of developing Alzheimer’s disease.” (1)
According to Prof. Tara Spires-Jones, Director of the Centre for Discovery Brain Sciences at the University of Edinburgh:
“The blood test in this study looks for 3 proteins, phosphorylated tau protein which indicates Alzheimer’s disease pathology building up in the brain, GFAP, a marker of brain inflammation, and neuro filament light chain protein which is a marker of neurodegeneration.“ (4)
The hope is that if the blood test proves effective, it can open up early detection of Alzheimer’s to so many more people, even offering an at-home test in the future. As the Study website explains:
“Brain scans detecting amyloid and tau levels can be expensive and inaccessible for many people. Using blood and digital biomarkers for detection is simpler, cost effective, and accessible for all.” (2)
The Bio-Hermes-002 (2) study
The study involves people aged from 60 to 90 years, with or without memory loss. It is led by LifeArc, a medical research charity and the Global Alzheimer’s Platform Foundation, and supported by UK Dementia Research Institute. All volunteers involved must be willing to undergo an MRI brain scan, amyloid PET (Positron Emission Tomography) scan, tau PET scan, and a blood test.
As Dr Lalli at LifeArc explained:
“Developing cheaper, scalable and more accessible tests is vital in the battle against this devastating condition … We are excited about the prospect of a finger-prick blood test for Alzheimer’s disease because it will allow more patients to access new drugs, currently being developed, to slow disease progression in its early stages.” (5)
Early detection of risk for millions
The results could change millions of lives, enabling them to adjust their lifestyles and access new treatments to reduce their risk, according to Prof B. Paul Morgan, Director, UK Dementia Research Institute Cardiff:
“If successful, then the blood test could be widely used in at-risk populations to identify those with incipient Alzheimer’s who would most benefit from current and future treatments, including lifestyle interventions and the recent crop of amyloid-targeting drugs.” (4)
According to the Alzheimer’s Association, around 1 in 9 people (10.9%) age 65 and older has Alzheimer’s. However, the impact is much wider, with between 10 and 12 individuals directly impacted for every person who is diagnosed with dementia. Vytality at Home are closely involved with Gordie Howe CARES (3), a charity which offers personalized and practical expert guidance to caregivers for those with Alzheimer’s “in the moments when support is needed most”.
Home care for those living with dementia and Alzheimer’s Disease
At Vytality at Home, we offer practical and informed home care for those living with dementia, and those who look after them. Home care services can enable those with a diagnosis of dementia to live at home for longer, with personalized care plans that can adapt to their changing requirements over time. Home care is a sustainable, viable and affordable alternative for those in the early stages, who do not require (or want) the 24/7 services of a specialist dementia care home.
For more details, see our dementia care page.
Or contact us to discuss your dementia care requirements:
About the Author
Nicole Dyer is Co-Founder & Co-President of Vytality at Home. She is a seasoned leader in senior living and healthcare operations, with over 20 years of experience driving innovation and growth in the sector. Nicole is a member of CPHR Alberta, and is an Ad Hoc Board Member and Administrator for Gordie Howe CARES, a charity working for the advancement of Alzheimer’s and dementia-related programming and events in Calgary.
SOURCES:
(1)
Walsh, F. (2026, January 19). Alzheimer’s finger-prick test could help diagnosis. BBC News. https://www.bbc.co.uk/news/articles/cq5y85e8d2xo
(2)
Global Alzheimer’s Platform Foundation. (n.d.). Do you want to make a difference in Alzheimer’s research? Retrieved January 19, 2026, from https://globalalzplatform.org/biohermes-002study/
(3)
Gordie Howe CARES. (n.d.). Gordie Howe CARES. Retrieved January 19, 2026, from https://www.gordiehowecares.com/
(4)
Science Media Centre. (2026, January 19). Expert reaction to launch of trial to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease [Press release]. https://www.sciencemediacentre.org/expert-reaction-to-launch-of-trial-to-test-whether-a-finger-prick-style-blood-test-could-be-used-to-help-diagnose-alzheimers-disease/
(5)
Stewart, A. (2026, January 19). Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin [News release]. LifeArc. https://www.lifearc.org/2026/finger-prick-blood-test-alzheimers-disease/


